We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
Cap. Flow
-$22.2M
Cap. Flow %
-0.1%
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$74.9M
2
KEYS icon
Keysight
KEYS
+$52.1M
3
MRK icon
Merck
MRK
+$40.9M
4
ABBV icon
AbbVie
ABBV
+$38.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$37.7M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$104M
2
MTCH icon
Match Group
MTCH
+$48.9M
3
TDG icon
TransDigm Group
TDG
+$43.4M
4
SYK icon
Stryker
SYK
+$43.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$42.5M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Financials 14.31%
3 Healthcare 13.92%
4 Consumer Discretionary 9.62%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGIH icon
1876
LGI Homes
LGIH
$1.4B
$61K ﹤0.01%
+700
New +$49.1K
VC icon
1877
Visteon
VC
$2.77B
$61K ﹤0.01%
+900
New +$56.6K
CDTX
1878
DELISTED
Cidara Therapeutics
CDTX
$60K ﹤0.01%
+820
New +$53.1K
AFG icon
1879
American Financial Group
AFG
$11.9B
$59K ﹤0.01%
936
-13,856
-94% -$893K
DXC icon
1880
DXC Technology
DXC
$1.63B
$59K ﹤0.01%
3,599
-22,278
-86% -$354K
KDNY
1881
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$59K ﹤0.01%
+5,160
New +$71.1K
AC
1882
DELISTED
Associated Capital Group
AC
$58K ﹤0.01%
1,608
+1,507
+1,492% +$53.9K
DINO icon
1883
HF Sinclair
DINO
$15.9B
$58K ﹤0.01%
2,016
-5,492
-73% -$163K
FULC icon
1884
Fulcrum Therapeutics
FULC
$248M
$58K ﹤0.01%
3,200
MCBS icon
1885
MetroCity Bankshares
MCBS
$1.05B
$58K ﹤0.01%
4,100
TRGP icon
1886
Targa Resources
TRGP
$60.4B
$58K ﹤0.01%
2,923
-65,125
-96% -$979K
WK icon
1887
Workiva
WK
$2.94B
$58K ﹤0.01%
+1,100
New +$45.1K
TCFC
1888
DELISTED
The Community Financial Corporation Common Stock
TCFC
$58K ﹤0.01%
2,400
STOK icon
1889
Stoke Therapeutics
STOK
$1.82B
$57K ﹤0.01%
2,400
COLB icon
1890
Columbia Banking Systems
COLB
$8.81B
$56K ﹤0.01%
2,000
-4,200
-68% -$107K
JLL icon
1891
Jones Lang LaSalle
JLL
$15.1B
$56K ﹤0.01%
547
-6,230
-92% -$642K
KRMD icon
1892
KORU Medical Systems
KRMD
$176M
$56K ﹤0.01%
+6,300
New +$63.7K
SUM
1893
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$56K ﹤0.01%
3,560
+1,831
+106% +$26.3K
MIDD icon
1894
Middleby
MIDD
$6.05B
$55K ﹤0.01%
701
PACK icon
1895
Ranpak Holdings
PACK
$553M
$55K ﹤0.01%
+7,400
New +$54.4K
MMAC
1896
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$55K ﹤0.01%
2,400
DSSI
1897
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$55K ﹤0.01%
6,900
APT icon
1898
Alpha Pro Tech
APT
$50.4M
$54K ﹤0.01%
+3,100
New +$42.8K
FFBC icon
1899
First Financial Bancorp
FFBC
$3.55B
$54K ﹤0.01%
3,900
+1,600
+70% +$22K
QVCGA
1900
DELISTED
QVC Group Inc Series A
QVCGA
$54K ﹤0.01%
119

Similar funds

STRS Ohio's Q2 2020 Portfolio in Review

As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
  • STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
  • STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
  • STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
  • STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
  • STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
  • STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.